Skip to main content
AMCP Nexus 2023 Main banner

PreConference Program

(Preconference) Understanding the Fundamentals of IRA and its Impact

Monday, October 16, 2023
1:00 PM – 5:30 PM East Coast USA Time
Location: Crystal H
ACPE UAN:0233-0000-23-043-L03-P (Pharma Perspective)
0233-0000-23-068-L03-P (Payer Perspective) | Contact Hours: 4.0 Law CPE | Activity Type: Knowledge-Based
This pre-conference is intended for managed care pharmacists and professionals.

This will be an up-to-the-minute program that will provide valuable information for you and your organization as you work to optimize your navigation of the IRA.

This pre-conference program will offer two separate tracks to tailor the content to payers and pharmaceutical manufacturers. The patient perspective will be included in both tracks. Expert panelists and speakers will specialize in concepts such as:
• Negotiation and pricing
• Rebating
• Out-of-pocket smoothing
• Coordination and communication
• Considerations for preparing for IRA

With the Centers for Medicare and Medicaid Services (CMS) announcing the first 10 drugs selected for negotiation on September 1, attendees will hear about the ripple effect of drug price negotiation.

Join us at AMCP Nexus for a pre-conference session uncovering the current and anticipated impacts of the Inflation Reduction Act (IRA).

Registration for this pre-conference activity is separate from the AMCP Nexus 2023 meeting.
Registration Fees: $399 AMCP Members; $499 Non-members.

Learning Objectives::

At the completion of this activity, participants should be able to:
  1. Summarize the Inflation Reduction Act (IRA) law and its impact on pharmaceutical manufacturers, payers, and patients.
  2. Explain the implications of IRA beyond drug pricing impacts.
  3. Identify the latest developments and implications of the Medicare Drug Price Negotiation Program.
  4. Define how payers are responding to the direct and indirect effects of IRA including Part D redesign, catastrophic liability, and formulary management.